DANIEL J LOVELL, M.D.
Medical Practice in Cincinnati, OH

License number
Ohio 35-05-0797
Category
Medical Practice
Type
Pediatric Rheumatology
Address
Address
3333 Burnet Ave Ml, Cincinnati, OH 45229
Phone
(513) 636-7686
(513) 636-5568 (Fax)

Personal information

See more information about DANIEL J LOVELL at radaris.com
Name
Address
Phone
Daniel Lovell, age 75
9605 Brayes Manor Dr, Mentor, OH 44060
(440) 655-5853
Daniel Lovell, age 73
599 Fox Run Cir, Newark, OH 43055
(740) 344-7784
Daniel Lovell
152 Irving Wick Dr E LOT 89, Heath, OH 43056
Daniel Lovell, age 72
295 Bridle Pass Way, Monroe, OH 45050
(513) 314-9610
Daniel Lovell, age 73
2326 Easthill Ave, Cincinnati, OH 45208

Organization information

See more information about DANIEL J LOVELL at bizstanding.com

Daniel J Lovell MD

3333 Burnet Ave, Cincinnati, OH 45229

Industry:
Medical Doctor's Office
Administrative Assistants:
Scott Pentiuk (Gastroenterology),Katlin A. Blomer (Family And General Dentistry),Alicia N. Wilmoth (Cardiology),...

Professional information

See more information about DANIEL J LOVELL at trustoria.com
Daniel J Lovell Photo 1
Dr. Daniel J Lovell, Cincinnati OH - MD (Doctor of Medicine)

Dr. Daniel J Lovell, Cincinnati OH - MD (Doctor of Medicine)

Specialties:
Pediatric Rheumatology
Address:
Cincinnati Office
3333 Burnet Ave, Cincinnati 45229
(513) 636-4751 (Phone), (513) 636-8145 (Fax)
Cincinnati Childrens Rheumtlgy
3333 Burnet Ave SUITE E2, Cincinnati 45229
(513) 636-4676 (Phone)
Certifications:
Pediatric Rheumatology, 2000, Pediatrics, 1984
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Univ Of Ks Sch Of Med
Graduated: 1978
Chldns Mercy Hosp
Baylor College of Medicine


Daniel Joe Lovell Photo 2
Daniel Joe Lovell, Cincinnati OH

Daniel Joe Lovell, Cincinnati OH

Specialties:
Pediatric Rheumatologist
Address:
3333 Burnet Ave, Cincinnati, OH 45229
Education:
University of Kansas, School of Medicine - Doctor of Medicine
Baylor Clinic & Hospital - Fellowship - Pediatric Rheumatology (Pediatrics)
Children's Mercy Hospital - Residency - Pediatrics
Board certifications:
American Board of Pediatrics Certification in Pediatrics, American Board of Pediatrics Sub-certificate in Pediatric Rheumatology (Pediatrics)


Daniel Lovell Photo 3
Uses And Compositions For Treatment Of Rheumatoid Arthritis

Uses And Compositions For Treatment Of Rheumatoid Arthritis

US Patent:
2008016, Jul 10, 2008
Filed:
Apr 10, 2007
Appl. No.:
11/786442
Inventors:
Hartmut Kupper - Mutterstadt, DE
Jeffrey D. Kent - Deerfield IL, US
Mary A. Cifaldi - Gurnee IL, US
John L. Perez - Doylestown PA, US
Gerd R. Burmester - Berlin, DE
Philip Mease - Seattle WA, US
Daniel J. Lovell - Cincinnati OH, US
Edward Keystone - Toronto, CA
Arthur Kavanaugh - San Diego CA, US
International Classification:
A61K 39/395, G01N 33/68, A61K 39/09, A61K 39/145, A61P 37/00, A61P 19/02
US Classification:
4241361, 4241581, 436 86, 514 12, 4241331, 4241421, 4242441, 4242091
Abstract:
The invention provides methods, uses and compositions for the treatment of rheumatoid arthritis. The invention describes methods and uses for treating rheumatoid arthritis wherein a TNFα inhibitor, such as a human TNFα antibody, or antigen-binding portion thereof. Also described are methods for determining the efficacy of a TNFα inhibitor for treatment of rheumatoid arthritis in a subject.


Daniel Lovell Photo 4
Uses And Compositions For Treatment Of Juvenile Rheumatoid Arthritis

Uses And Compositions For Treatment Of Juvenile Rheumatoid Arthritis

US Patent:
2008011, May 22, 2008
Filed:
Jun 11, 2007
Appl. No.:
11/811873
Inventors:
John R. Medich - East Hanover NJ, US
Nicolino Ruperto - Rapallo, IT
Alberto Martini - Piacenza, IT
Daniel J. Lovell - Cincinnati OH, US
Edward Giannini - Cincinnati OH, US
International Classification:
A61K 39/00, G01N 33/53, B65D 69/00
US Classification:
4241301, 435 71, 220890
Abstract:
The invention provides methods, uses and compositions for the treatment of juvenile rheumatoid arthritis (JRA). The invention describes methods and uses for treating JRA, wherein a TNFα inhibitor, such as a human TNFα antibody, or antigen-binding portion thereof, is used to prevent flare-ups associated with JRA. Also described are methods for determining the efficacy of a TNFα inhibitor for treatment of JRA in a subject.